🇺🇸 FDA
Patent

US 11104712

Methods for modulating an immune response

granted A61KA61K2039/505A61K38/1774

Quick answer

US patent 11104712 (Methods for modulating an immune response) held by Cue Biopharma, Inc. expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cue Biopharma, Inc.
Grant date
Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K38/1774, A61K38/2013, A61K39/3955